Additionally, in cervical cancer, NAT10-mediated ac4C modification upregulates the expression of FOXP1, thereby reprogramming the glycolytic metabolic pathway to promote malignant progression of cervical cancer 14. Here, FOXP1 is linked to cervical carcinoma.